It has been shown to correlate well with conventional AD biomarkers such as CSF Aβ42 [11], C-Pittsburgh compound B positron emission tomography standardized uptake value ratio, CSF phosphorylated tau and CSF total tau [11]. This evidence concerns the gene MAPT and Alzheimer disease.